Novartis touts phase III prostate cancer study results

Novartis is highlighting results from a phase III study that has investigate...Read more on AuntMinnie.comRelated Reading: Preclinical lung imaging offers effective evaluation of drug candidates Small study supports radiation before CAR-T therapy Firm nabs $1.4M for prostate cancer drug Ga-68 DOTATATE PET/MRI could be boon for meningioma Novartis to buy Endocyte for $2.1B
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news